Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258) (NCT06898515)
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II)
🩺 Plain-English Summary (8th-Grade Level)
The objective of this study is to prospectively compare decongestive therapy administered by the Reprieve System to Optimal Diuretic Therapy (ODT) in the treatment of patients diagnosed with acute decompensated heart failure (ADHF). The main objective is to determine if the Reprieve System can more efficiently decongest ADHF patients in comparison to Control Therapy.
Who can join: Review the eligibility criteria below.
Location: University of California Irvine — Irvine, California
Age range: 22 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (53 Sites)
Showing the first 25 of 53 sites.
- University of California Irvine — Irvine, California
- Scripps Memorial Hospital — La Jolla, California
- UC Davis Medical Center — Sacramento, California
- University of Florida — Gainesville, Florida
- Piedmont Atlanta Hospital — Atlanta, Georgia
- Piedmont Augusta Hospital — Augusta, Georgia
- Northeast Georgia Medical Center — Gainesville, Georgia
- Advocate Christ Medical Center — Oak Lawn, Illinois
- University of Kansas Medical Center — Kansas City, Kansas
- University of Louisville Hospital — Louisville, Kentucky
- Trinity Health Ann Arbor Hospital — Ann Arbor, Michigan
- Corewell Health Butterworth Hospital — Grand Rapids, Michigan
- Corewell William Beaumont University Hospital — Royal Oak, Michigan
- Minneapolis Heart Institute — Minneapolis, Minnesota
- University of Mississippi — Jackson, Mississippi
- Harry S. Truman Veteran's Memorial Hospital — Columbia, Missouri
- St. Louis VA — St Louis, Missouri
- Washington University — St Louis, Missouri
- University of Nebraska Medical Center — Omaha, Nebraska
- Stony Brook University Hospital — Stony Brook, New York
- Duke University — Durham, North Carolina
- Moses H. Cone Memorial Hospital — Greensboro, North Carolina
- Atrium Health Wake Forest Baptist Medical Center — Winston-Salem, North Carolina
- Lindner Center at Christ Hospital — Cincinnati, Ohio
- University of Cincinnati — Cincinnati, Ohio
📞 Contact the Study Coordinator
Phone: (617) 848-0400
Email: aforrest@reprievecardio.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Acute Decompensated Heart Failure
- IC14 for Treatment of Acute Decompensated Heart Failure — Charlottesville, Virginia
- A Study Of Acute Decompensated Heart Failure — Rochester, Minnesota
- Low Level Tragus Stimulation in Acute Decompensated Heart Failure — Oklahoma City, Oklahoma
- Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure — Farmington, Connecticut
Explore by condition: All Acute Decompensated Heart Failure clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.